The persistence of IL-17A+ cells within the airway mucosa of people with chronic lung disease may not only sustain inflammation, but may also alter essential host defence to respiratory infections, leading to excessive inflammatory responses during exacerbations. The gene discussed is IL17A; the disease is chronic lung disease.